Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
Holding PHIO?
Track your performance easily

Phio Pharmaceuticals (PHIO) Income Statement

465 Followers

Phio Pharmaceuticals Income Statement

Last quarter (Q2 2024), Phio Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Phio Pharmaceuticals's net income was $-1.85M. See Phio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 21.00K
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 5.03M$ 10.70M$ 11.46M$ 13.51M$ 8.79M$ 9.01M
Operating Income
$ -9.45M$ -10.70M$ -11.46M$ -13.51M$ -8.79M$ -8.99M
Net Non Operating Interest Income Expense
---$ 224.00K$ -1.00K-
Other Income Expense
$ -117.00K$ 128.00K$ 18.00K$ -233.00K$ -1.00K$ 79.00K
Pretax Income
$ -4.91M$ -10.83M$ -11.48M$ -13.29M$ -8.79M$ -8.91M
Tax Provision
-$ -2.55M$ -2.29M$ -4.34M$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.33M$ -10.83M$ -11.48M$ -13.29M$ -8.79M$ -8.91M
Basic EPS
$ -6.70$ -5.20$ -10.10-$ -1.92$ -19.35
Diluted EPS
$ -6.70$ -5.20$ -10.10$ -12.48$ -1.92$ -19.35
Basic Average Shares
$ 1.74B$ 2.08M$ 1.14M$ 1.07M$ 4.59M$ 460.35K
Diluted Average Shares
$ 1.74B$ 2.08M$ 1.14M$ 1.07M$ 4.59M$ 460.35K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.03M$ 10.82M$ 11.46M$ 13.51M$ 8.79M$ 9.01M
Net Income From Continuing And Discontinued Operation
$ -9.33M$ -10.83M$ -11.48M$ -13.29M$ -8.79M$ -8.91M
Normalized Income
$ -6.04M-$ -13.77M-$ -8.79M$ -8.91M
Interest Expense
------
EBIT
$ -4.91M$ -13.38M$ -11.48M$ -13.29M$ -8.79M$ -8.99M
EBITDA
$ -4.78M$ -13.19M$ -11.29M$ -13.10M$ -8.72M$ -8.92M
Currency in USD

Phio Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis